We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
676
ING
ING
$93.6B
| $55K | ﹤0.01% |
3,656
| – | – |
2022 Q1
7 quarters
|
|
677
Pinnacle West Capital
PNW
$12.5B
| $55K | ﹤0.01% |
771
+262
| +51% | +$19.3K |
2022 Q1
7 quarters
|
|
678
SM Energy
SM
$9.24B
| $55K | ﹤0.01% |
1,400
| – | – |
2022 Q1
7 quarters
|
|
679
Avista
AVA
$3.09B
| $54K | ﹤0.01% |
1,500
| – | – |
2022 Q1
7 quarters
|
|
680
Churchill Downs
CHDN
$5.79B
| $54K | ﹤0.01% |
400
| – | – |
2023 Q2
2 quarters
|
|
681
Medpace
MEDP
$17.4B
| $54K | ﹤0.01% |
175
+100
| +133% | +$27K |
2022 Q1
7 quarters
|
|
682
Vontier
VNT
$4.6B
| $54K | ﹤0.01% |
1,542
| – | – |
2022 Q1
7 quarters
|
|
|
LK
683
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
| $54K | ﹤0.01% |
2,000
| – | – |
2022 Q1
7 quarters
|
|
684
Atlanta Braves Holdings Series A
BATRA
$3.54B
| $53K | ﹤0.01% |
1,225
| – | – |
2022 Q3
5 quarters
|
|
685
First Trust Financials AlphaDEX Fund
FXO
$1.06B
| $53K | ﹤0.01% |
1,210
| – | – |
2022 Q1
7 quarters
|
|
686
VanEck Junior Gold Miners ETF
GDXJ
$8.01B
| $53K | ﹤0.01% |
1,400
| – | – |
2023 Q3
1 quarter
|
|
687
iShares Morningstar Small-Cap Value ETF
ISCV
$673M
| $53K | ﹤0.01% |
+882
| New | +$46.6K |
2023 Q4
0 quarters
|
|
688
Packaging Corp of America
PKG
$21.3B
| $53K | ﹤0.01% |
324
+74
| +30% | +$11.6K |
2022 Q1
7 quarters
|
|
689
Box
BOX
$5.73B
| $52K | ﹤0.01% |
2,000
| – | – |
2022 Q1
7 quarters
|
|
690
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.9B
| $52K | ﹤0.01% |
476
| – | – |
2022 Q2
6 quarters
|
|
691
Workday
WDAY
$49.2B
| $52K | ﹤0.01% |
+190
| New | +$45.2K |
2023 Q4
0 quarters
|
|
692
AGNC Investment Corp Series C
AGNCN
$303M
| $51K | ﹤0.01% |
+2,000
| New | +$50.2K |
2023 Q4
0 quarters
|
|
693
Brunswick
BC
$4.26B
| $51K | ﹤0.01% |
520
| – | – |
2022 Q1
7 quarters
|
|
694
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $51K | ﹤0.01% |
2,048
| – | – |
2023 Q2
2 quarters
|
|
695
iShares Core Universal USD Bond ETF
IUSB
$49.2B
| $51K | ﹤0.01% |
1,110
| – | – |
2022 Q1
7 quarters
|
|
696
RPM International
RPM
$12.8B
| $51K | ﹤0.01% |
459
| – | – |
2022 Q1
7 quarters
|
|
697
DELISTED
Dynavax Technologies
DVAX
| $50K | ﹤0.01% |
+3,500
| New | +$48.6K |
2023 Q4
0 quarters
|
|
698
APA Corp
APA
$17.5B
| $49K | ﹤0.01% |
1,350
| – | – |
2023 Q3
1 quarter
|
|
699
H.B. Fuller
FUL
$2.72B
| $49K | ﹤0.01% |
600
| – | – |
2022 Q1
7 quarters
|
|
700
GSK
GSK
$101B
| $49K | ﹤0.01% |
1,319
-240
| -15% | -$8.62K |
2022 Q1
7 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.